WASHINGTON (SPECTRUM NEWS) — Congresswoman Gwen Moore, D-Milwaukee is pushing lawmakers to pass legislation aimed at lowering drug costs during the district work break.

But there’s a battle to move the needle on the issue in Washington.

Joe Grogan, the director of the Domestic Policy Council, believes the bipartisan promise to take on “Big Pharma” has seemingly been muted by House Democrats’ investigations into the president.

But he says the administration would still be willing to strike a deal.

“When the fever breaks and this whole impeachment stuff is behind us, they are going to need to focus on finding real solutions,” said Grogan. “And we think we will be in a great position.”

Rep. Moore away from Capitol Hill and back in her district on Wednesday — led candid conversations between her supporters on the need for Washington to act now.

“They gave me more than one example of people who could not afford their prescription drugs and it really caused some economic havoc within the families,” said Rep. Moore.

The congresswoman says hope could be on the way.

House Democrats rolled out the “Lower Drug Cost Now Act” (H.R. 3) last month and House Speaker Nancy Pelosi is planning on bringing it to the House floor for a vote soon.

The bill would make lower prices negotiated by Medicare available to everyone, limit co-pays for seniors and slap penalties on pharmaceutical companies if their prices surge.

Rep. Moore says while lawmakers on both sides of aisle can find common ground on this cause, she’s concerned Senate Majority Leader Mitch McConnell won’t play ball.

“We are urging our constituents to contact their US senators and urge them, especially here in Wisconsin (Sen. Ron Johnson), to urge Mitch McConnell to allow H.R. 3 to get a vote, up or down. And to allow the other prescription drug bills that have already been parked, buried in the graveyard to come up for a vote.”